Status: current, Defined. Date: 30-Jun 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 979041491000036115 | leuprorelin acetate 30 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 979041501000036110 | inert substance diluent [1 syringe] (&) leuprorelin acetate 30 mg modified release injection [1 x 30 mg syringe], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| leuprorelin acetate 30 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| leuprorelin acetate 30 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack | has MPUU | leuprorelin acetate 30 mg modified release injection, syringe | true | Inferred relationship | Some | 1 | |
| leuprorelin acetate 30 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack | has MPUU | inert substance diluent, syringe | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eligard 4 Month (1 x 30 mg syringe, 1 x inert diluent syringe), 1 pack | Is a | True | leuprorelin acetate 30 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR